Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
Jacobson
M A
MA
Department of Medicine, University of California, San Francisco.
Crowe
S
S
Levy
J
J
Aweeka
F
F
Gambertoglio
J
J
McManus
N
N
Mills
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000150:complications; D017245:Foscarnet; D006678:HIV / Q000302:isolation & purification; D015488:HIV Antigens / Q000032:analysis; D006801:Humans; D007262:Infusions, Intravenous; D007963:Leukocytes, Mononuclear / Q000382:microbiology; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012173:Retinitis / Q000150:complications
D000998:Antiviral Agents; D015488:HIV Antigens; D009943:Organophosphorus Compounds; D017245:Foscarnet; D010746:Phosphonoacetic Acid